Research output per year
Research output per year
Personal profile
Research
As a senior consultant of oncology specialized in endcrine tumors and radionuclide therapy, my research focuses on optimizing peptide receptor radionuclide therapy for patients with neuroendocrine tumors. The research is conducted in close collaboration with the department of medical radiation physics.
UKÄ subject classification
- Cancer and Oncology
Fingerprint
Dive into the research topics where Anna Sundlöv is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Dosimetric quantities of neuroendocrine tumors over treatment cycles with 177Lu-DOTA-TATE
Roth, D., Gustafsson, J., Warfvinge, C. F., Sundlöv, A., Åkesson, A., Tennvall, J. & Sjögreen Gleisner, K., 2022 Mar, In: Journal of Nuclear Medicine. 63, 3, p. 399-405 7 p.Research output: Contribution to journal › Article › peer-review
-
Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres
Shahida, B., Tsoumani, K., Planck, T., Modhukur, V., Asp, P., Sundlöv, A., Tennvall, J., Åsman, P., Lindgren, O. & Lantz, M., 2022, In: Endocrine. 75, 3, p. 856-864Research output: Contribution to journal › Article › peer-review
Open Access -
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients
Sundlöv, A., Gleisner, K. S., Tennvall, J., Ljungberg, M., Warfvinge, C. F., Holgersson, K., Hallqvist, A., Bernhardt, P. & Svensson, J., 2022, In: European Journal of Nuclear Medicine and Molecular Imaging. 49, 11 , p. 3830-3840Research output: Contribution to journal › Article › peer-review
Open Access -
Relationship between somatostatin receptor expressing tumour volume and health-related quality of life in patients with metastatic GEP-NET
Ohlsson, H., Gålne, A., Trägårdh, E., Malmström, M., Sundlöv, A. & Almquist, M., 2022, In: Journal of Neuroendocrinology. 34, 6Research output: Contribution to journal › Article › peer-review
Open Access -
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
Stenvall, A., Gustafsson, J., Larsson, E., Roth, D., Sundlöv, A., Jönsson, L., Hindorf, C., Ohlsson, T. & Sjögreen Gleisner, K., 2022, In: EJNMMI Research. 12, 1, 75.Research output: Contribution to journal › Article › peer-review
Open Access
Projects
- 3 Active
-
Towards personalized radionuclide therapy
Asp, P., Gunnlaugsson, A., Sundlöv, A. & Sjögreen Gleisner, K.
2021/12/01 → …
Project: Dissertation
-
Efficacy and toxicity of peptide-receptor radionuclide therapy: investigation of dose-effect relationships
Warfvinge, C. F., Sjögreen Gleisner, K., Sundlöv, A., Ljungberg, M. & Gunnlaugsson, A.
2020/02/01 → 2024/04/20
Project: Dissertation
-
PET-CT imaging of neuroendocrine tumors - In relationship to treatment, quality of life and artificial intelligence
Gålne, A., Trägårdh, E., Sundlöv, A., Enqvist, O. & Wasselius, J.
2018/12/14 → 2024/05/30
Project: Dissertation